// App-Quantinova.ai

: Immunogenicity of new treatments: Current status of knowledge

Researchers

Presenter

  • D. Lillicrap

Principal Investigators

  • N/A

Medical Centers

  • Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • NN7415

  • rFVIII

  • FVIII

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Bayer

Result

  • N/A